APA

Postema A. W., Scheltema M. J. V., Mannaerts C. K., Van Sloun R. J. G., Idzenga T., Mischi M., Engelbrecht M. R. E., De la Rosette J. J. M. C. H. & Wijkstra H. (20170821). The prostate cancer detection rates of CEUS-targeted versus MRI-targeted versus systematic TRUS-guided biopsies in biopsy-naïve men: a prospective, comparative clinical trial using the same patients. : BMC urology.

Chicago

Postema A W, Scheltema M J V, Mannaerts C K, Van Sloun R J G, Idzenga T, Mischi M, Engelbrecht M R E, De la Rosette J J M C H and Wijkstra H. 20170821. The prostate cancer detection rates of CEUS-targeted versus MRI-targeted versus systematic TRUS-guided biopsies in biopsy-naïve men: a prospective, comparative clinical trial using the same patients. : BMC urology.

Harvard

Postema A. W., Scheltema M. J. V., Mannaerts C. K., Van Sloun R. J. G., Idzenga T., Mischi M., Engelbrecht M. R. E., De la Rosette J. J. M. C. H. and Wijkstra H. (20170821). The prostate cancer detection rates of CEUS-targeted versus MRI-targeted versus systematic TRUS-guided biopsies in biopsy-naïve men: a prospective, comparative clinical trial using the same patients. : BMC urology.

MLA

Postema A W, Scheltema M J V, Mannaerts C K, Van Sloun R J G, Idzenga T, Mischi M, Engelbrecht M R E, De la Rosette J J M C H and Wijkstra H. The prostate cancer detection rates of CEUS-targeted versus MRI-targeted versus systematic TRUS-guided biopsies in biopsy-naïve men: a prospective, comparative clinical trial using the same patients. : BMC urology. 20170821.